Moffitt Cancer Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
Moffitt Cancer Center

Moffitt Cancer Center

12902 USF Magnolia Drive
Tampa, Florida, United States
Email   Phone   Web  

Moffitt Cancer Center is at the very forefront of cancer centers worldwide in pioneering advances like CAR T-cell therapy, a promising approach to immunotherapy that uses a patient’s own immune cells to recognize and attack their tumors. 

Moffitt Cancer Center’s Malignant Hematology Program, one of the largest Myelodysplastic Syndromes (MDS) programs in the nation, provides comprehensive, multispecialty treatment for patients with all forms of MDS and acute myeloid leukemia (AML). They understand that each patient responds differently to therapy, so their experienced team of oncologists, hematologists, medical oncologists, supportive care providers and other team members thoroughly assess each patient’s case to determine the most appropriate options for working toward remission and bringing blood cell counts as close to normal as possible. A patient’s individualized recommendation might include a combination of the following MDS therapies:

• Chemotherapy

• Immunotherapy

• Targeted therapy

• Stem cell and bone marrow transplants

At Moffitt, all MDS therapies are provided in a single location, making it easier for patients to access the outstanding treatments they deserve without the stress of traveling from clinic to clinic.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close